Table 1 summarizes characteristics of participants with lifetime AUD from COGA, separately reporting EA and AA individuals. In COGA EA, a total of 41.09% participants met criteria for 12-month remission, with similar proportions of participants having abstinent and non-abstinent remission. PGSAUD did not differ between individuals with current AUD and participants with 12-month remission, but compared to the current AUD group, the 12-month remission group was more likely to be female and younger, to have a longer AUD duration, higher AUD criterion count and maxdrinks24, a higher prevalence of family history of remission, and to have accessed any treatment, particularly mutual help and both mutual help and professional treatment. Results for the abstinent subgroup were similar except abstinent individuals were comparable in age and sex composition to individuals with current AUD. Interestingly, compared to those with current AUD, non-abstinent individuals had significantly lower PGSAUD, met fewer AUD criteria and had lower maxdrinks24, and were less likely to have accessed any treatment (mostly due to lower endorsement of both professional treatment and mutual help participation).
